EMA Assessing 'Slightly' Raised Heart Attack Risk With Two COVID-19 Vaccines

Moderna's Spikevax Linked To Flare-Up Of Capillary Leak Syndrome

The EU’s latest safety report on coronavirus vaccines looks at the risk of myocardial infarction, pulmonary embolism, thrombosis and capillary leak syndrome following vaccination.

The concept of a coronavirus vaccine. syringe and covid-19 virus on a white background
The safety of COVID-19 vaccines is kept under constant surveillance • Source: Alamy

The European Medicines Agency’s pharmacovigilance risk assessment committee (PRAC) has begun evaluating reports of myocardial infarction following the administration of two coronavirus vaccines, COVID-19 Vaccine Janssen and AstraZeneca PLC/Oxford University’s Vaxzevria. Reports of pulmonary embolism and thromboses with Vaxzevria are also being investigated.

The EMA said PRAC was aware of the results of an epidemiological study based on French national databases and posted...

Welcome to Pink Sheet

Create an account to read this article

More from Vaccines

More from Pink Sheet